Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalba Minelli

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Current Drug Delivery|February 7, 2014
New chitosan nanospheres for the delivery of 5-fluorouracil: preparation, characterization and in vitro studiesRoberta Cavalli, Federica Leone, Rosalba Minelli, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 25, 2012
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cellsRosalba Minelli, Roberta Cavalli, Leigh Ellis, et al.
Frontiers in Physiology|September 13, 2013
Interaction of aldehydes derived from lipid peroxidation and membrane proteinsStefania Pizzimenti, Eric Ciamporcero, Martina Daga, et al.
The Journal of Nutritional Biochemistry|September 8, 2009
4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activityStefania Pizzimenti, Elisa Menegatti, Daniela Berardi, et al.
Journal of Cellular and Molecular Medicine|November 17, 2009
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cellsCristina Toaldo, Stefania Pizzimenti, Angelo Cerbone, et al.
Plos One|July 5, 2012
Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cellsAngelo Cerbone, Cristina Toaldo, Rosalba Minelli, et al.
PPAR Research|May 24, 2012
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer CellsAngelo Cerbone, Cristina Toaldo, Stefania Pizzimenti, et al.
Free Radical Biology & Medicine|August 6, 2011
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cellsPiergiorgio Pettazzoni, Eric Ciamporcero, Claudio Medana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cellsChiara Dianzani, Rosalba Minelli, Riccardo Mesturini, et al.
Free Radical Biology & Medicine|November 17, 2010
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cellsPiergiorgio Pettazzoni, Stefania Pizzimenti, Cristina Toaldo, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current Drug Delivery|February 7, 2014
New chitosan nanospheres for the delivery of 5-fluorouracil: preparation, characterization and in vitro studiesRoberta Cavalli, Federica Leone, Rosalba Minelli, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 25, 2012
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cellsRosalba Minelli, Roberta Cavalli, Leigh Ellis, et al.
Frontiers in Physiology|September 13, 2013
Interaction of aldehydes derived from lipid peroxidation and membrane proteinsStefania Pizzimenti, Eric Ciamporcero, Martina Daga, et al.
The Journal of Nutritional Biochemistry|September 8, 2009
4-hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activityStefania Pizzimenti, Elisa Menegatti, Daniela Berardi, et al.
Journal of Cellular and Molecular Medicine|November 17, 2009
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cellsCristina Toaldo, Stefania Pizzimenti, Angelo Cerbone, et al.
Plos One|July 5, 2012
Rosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cellsAngelo Cerbone, Cristina Toaldo, Rosalba Minelli, et al.
PPAR Research|May 24, 2012
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer CellsAngelo Cerbone, Cristina Toaldo, Stefania Pizzimenti, et al.
Free Radical Biology & Medicine|August 6, 2011
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cellsPiergiorgio Pettazzoni, Eric Ciamporcero, Claudio Medana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cellsChiara Dianzani, Rosalba Minelli, Riccardo Mesturini, et al.
Free Radical Biology & Medicine|November 17, 2010
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cellsPiergiorgio Pettazzoni, Stefania Pizzimenti, Cristina Toaldo, et al.
Pageof 4